Institutions / Barclays PLC / Activity
Activity — Barclays PLC
49,937 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2023 as of | Exit | 10552T107 Common stock | $-3 | -2 -100.00% | 0 | low |
| Q3 2023 as of | Exit | 55003A108 Common stock | $-3 | -1 -100.00% | 0 | low |
| Q1 2023 as of | New | 89532E208 Common stock | $3 | +4 | 4 0.00% of portfolio | low |
| Q3 2024 as of | Exit | PDSB PDS Biotechnology Corp Common Stock | $-3 | -1 -100.00% | 0 | low |
| Q4 2025 as of | Trim | 00507W206 Common stock | $-3 | -3 -75.00% | 1 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 92854T118 Common stock | $-3 | -100 -100.00% | 0 | low |
| Q1 2023 as of | Trim | 05351X101 Common stock | $-3 | -23K -75.17% | 7,517 0.00% of portfolio | low |
| Q4 2025 as of | Trim | 22053A107 Common stock | $-3 | -1 -20.00% | 4 0.00% of portfolio | low |
| Q2 2024 as of | Trim | G2007L121 Common stock | $-4 | -129 -79.63% | 33 0.00% of portfolio | low |
| Q2 2023 as of | New | 12482W309 Common stock | $4 | +3 | 3 0.00% of portfolio | low |
| Q3 2023 as of | Exit | 12482W309 Common stock | $-4 | -3 -100.00% | 0 | low |
| Q1 2025 as of | New | GXAI Gaxos.ai Inc. Common Stock | $4 | +3 | 3 0.00% of portfolio | low |
| Q3 2025 as of | Exit | OMEX Odyssey Marine Exploration Inc Common Stock | $-4 | -3 -100.00% | 0 | low |
| Q2 2025 as of | Exit | GXAI Gaxos.ai Inc. Common Stock | $-4 | -3 -100.00% | 0 | low |
| Q2 2023 as of | Exit | M26895132 Common stock | $-4 | -177 -100.00% | 0 | low |
| Q1 2025 as of | Exit | 608550208 Common stock | $-4 | -102 -100.00% | 0 | low |
| Q1 2025 as of | New | PZG Paramount Gold Nevada Corp. Common Stock | $4 | +12 | 12 0.00% of portfolio | low |
| Q2 2025 as of | Exit | PZG Paramount Gold Nevada Corp. Common Stock | $-4 | -12 -100.00% | 0 | low |
| Q1 2025 as of | New | 60743G100 Common stock | $4 | +5 | 5 0.00% of portfolio | low |
| Q3 2025 as of | New | VRCA Verrica Pharmaceuticals Inc. Common Stock | $4 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | VTGN Vistagen Therapeutics, Inc. Common Stock | $-4 | -1 -100.00% | 0 | low |
| Q4 2025 as of | New | 83370P201 Common stock | $4 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | Exit | 09609G209 Common stock | $-4 | -1 -100.00% | 0 | low |
| Q2 2025 as of | Exit | 60743G100 Common stock | $-4 | -5 -100.00% | 0 | low |
| Q4 2023 as of | Trim | G10830100 Common stock | $-4 | -4 -50.00% | 4 0.00% of portfolio | low |
| Q4 2025 as of | New | IBIO iBio, Inc. Common Stock | $4 | +2 | 2 0.00% of portfolio | low |
| Q3 2023 as of | Exit | 83587W205 Common stock | $-4 | -1 -100.00% | 0 | low |
| Q4 2025 as of | Exit | 04546C205 Common stock | $-4 | -4 -100.00% | 0 | low |
| Q4 2023 as of | New | KC Kingsoft Cloud Holdings Ltd ADR | $4 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | 49876K111 Common stock | $4 | +100 | 100 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 67421J108 Common stock | $-4 | -5 -100.00% | 0 | low |
| Q1 2023 as of | New | 75915K309 Common stock | $4 | +5 | 5 0.00% of portfolio | low |
| Q1 2023 as of | New | Baytex Energy Corp. Common stock | $4 | +1 | 1 0.00% of portfolio | low |
| Q1 2024 as of | Exit | 85569C107 Common stock | $-4 | -1 -100.00% | 0 | low |
| Q1 2024 as of | Exit | KC Kingsoft Cloud Holdings Ltd ADR | $-4 | -1 -100.00% | 0 | low |
| Q3 2024 as of | New | VATE INNOVATE Corp. Common Stock | $4 | +1 | 1 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 28202V207 Common stock | $-4 | -100 -100.00% | 0 | low |
| Q1 2025 as of | New | Palisade Bio, Inc. Common stock | $4 | +6 | 6 0.00% of portfolio | low |
| Q2 2025 as of | Exit | Palisade Bio, Inc. Common stock | $-4 | -6 -100.00% | 0 | low |
| Q1 2025 as of | New | 02115D208 Common stock | $5 | +5 | 5 0.00% of portfolio | low |
| Q1 2025 as of | New | TELA Bio, Inc. Common stock | $5 | +4 | 4 0.00% of portfolio | low |
| Q3 2025 as of | New | 20731J102 Common stock | $5 | +4 | 4 0.00% of portfolio | low |
| Q2 2025 as of | Exit | 68270C103 Common stock | $-5 | -10 -100.00% | 0 | low |
| Q2 2025 as of | Exit | TELA Bio, Inc. Common stock | $-5 | -4 -100.00% | 0 | low |
| Q2 2025 as of | Exit | 02115D208 Common stock | $-5 | -5 -100.00% | 0 | low |
| Q1 2025 as of | New | 68270C103 Common stock | $5 | +10 | 10 0.00% of portfolio | low |
| Q2 2024 as of | Exit | San Juan Basin Royalty Trust Common stock | $-5 | -1 -100.00% | 0 | low |
| Q4 2025 as of | Exit | XTNT Xtant Medical Holdings, Inc. Common Stock | $-5 | -8 -100.00% | 0 | low |
| Q4 2025 as of | Exit | 53620U508 Common stock | $-5 | -4 -100.00% | 0 | low |
| Q4 2025 as of | Exit | 20731J102 Common stock | $-5 | -4 -100.00% | 0 | low |